Spectrum Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Spectrum Pharmaceuticals generated cash of -$96,989,000, which is more than the previous year. Cash used in financing activities reached the amount of $75,591,000 last year. Net change in cash is therefore -$48,171,000.
Cash Flow
| 2013 | -2.08M | -14.33M | 35.25M |
|---|---|---|---|
| 2014 | -3.62M | -21.84M | 812K |
| 2015 | 6.74M | 2.83M | 1.47M |
| 2016 | -40.45M | -679K | 59.64M |
| 2017 | -38.85M | -1.08M | 108.72M |
| 2018 | -62.40M | 1.37M | -8.45M |
| 2019 | -134.63M | 31.99M | 9.62M |
| 2020 | -121.62M | 18.07M | 85.23M |
| 2021 | -119.48M | 108.71M | 53.31M |
| 2022 | -96.98M | -26.71M | 75.59M |
SPPI Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 88.53M | 46.00M | 64.41M | 157.48M | 227.32M | 158.22M | 139.74M | 129.94M | 156.30M | 139.69M |
Operating activities | ||||||||||
Net income | -75.40M | -158.62M | -160.86M | -112.68M | -120.01M | -91.24M | -68.51M | -50.78M | -45.71M | -62.13M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 248K | 286K | 261K | 3.33M | 28.40M | 27.97M | 26.49M | 31.86M | 25.35M | 22.09M |
Stock-based compensation expense | 8.49M | 19.84M | 17.81M | 21.83M | 17.48M | 15.13M | 12.41M | 12.08M | 11.80M | 12.42M |
| Deferred income tax benefit | 8.49M | 19.84M | 17.81M | 21.83M | 17.48M | 15.13M | 12.41M | 12.08M | 11.80M | 12.42M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -12.99M | 66K | 0 | 29.42M | 2.84M | 7.69M | -9.49M | 40.24M | -21.67M | 42.55M |
Inventories | -9.23M | 0 | 0 | -2.03M | 3.39M | 4.31M | -5.8M | 1.86M | 4.25M | 1.57M |
Accounts payable | -3.70M | -3.51M | -22.05M | -35.76M | 11.38M | 5.51M | -4.03M | -28.29M | 5.30M | -23.89M |
Cash generated by operating activities | -96.98M | -119.48M | -121.62M | -134.63M | -62.40M | -38.85M | -40.45M | 6.74M | -3.62M | -2.08M |
Investing activities | ||||||||||
Purchases Of Investments | -34.57M | -16.85M | -89.38M | -200.16M | 0 | -616K | -601K | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -273K | -221K | -5.53M | -9.01M | -2.75M | -465K | -78K | -223K | -934K | -3.16M |
Acquisitions Net | -2.16M | 5.97M | -3.95M | 158.57M | 0 | 0 | 0 | 0 | 0 | -11.16M |
Cash generated by investing activities | -26.71M | 108.71M | 18.07M | 31.99M | 1.37M | -1.08M | -679K | 2.83M | -21.84M | -14.33M |
Financing activities | ||||||||||
Common Stock Issued | 46.56M | 52.62M | 84.56M | 1.81M | 1.12M | 128.27M | 73.86M | 627K | 639K | 16.68M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | -6K | 0 | 0 | -207.38M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | -4.33M | -1.39M | -638K | -1.73M | -3.16M |
Repayments of term debt | 0 | 0 | 0 | 0 | -20K | 0 | -9.01M | 0 | 0 | -175M |
Cash used in financing activities | 75.59M | 53.31M | 85.23M | 9.62M | -8.45M | 108.72M | 59.64M | 1.47M | 812K | 35.25M |
Net Change In Cash | -48.17M | 42.53M | -18.40M | -93.06M | -69.84M | 69.10M | 18.48M | 9.79M | -26.36M | 16.60M |
Cash at end of period | 40.36M | 88.53M | 46.00M | 64.41M | 157.48M | 227.32M | 158.22M | 139.74M | 129.94M | 156.30M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |